The Hypoparathyroidism market continues to demonstrate robust expansion driven by innovative therapeutic developments and an increasing patient pool worldwide. Market dynamics in 2025 and 2026 reveal a significant shift in treatment paradigms, propelled by strategic market players enhancing product portfolios to address unmet clinical needs. These industry trends reflect evolving market...